The Rockefeller University

The Rockefeller University Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from The Rockefeller University, College & University, 1230 York Avenue, New York, NY.
(576)

Then and Now: Rockefeller's Junyue Cao! Don't miss this article from The Scientist on how Cao's work on the genomics of ...
09/03/2026

Then and Now: Rockefeller's Junyue Cao! Don't miss this article from The Scientist on how Cao's work on the genomics of aging has evolved.

Over the past four years, his team has improved their single-cell genomic tools to uncover genetic and epigenetic dynamic changes during aging, reframing what scientists know about the process.

Cell biologist Junyue Cao creates high-throughput single-cell methods to explore how aging shapes cells and organisms.

This review from Rockefeller's Titia de Lange highlights new insights into how   attrition guards against  , including i...
09/02/2026

This review from Rockefeller's Titia de Lange highlights new insights into how attrition guards against , including its role in limiting cell proliferation, the importance of telomere length at birth for lifelong cancer prevention, the mechanisms governing telomere length regulation and how telomerase activation enables malignant cells to bypass this barrier.

In contrast to the popular perception that telomere shortening is harmful, findings demonstrate that normal telomere attrition limits the risk of cancer and suggest that counteracting telomere attrition in healthy individuals (for example, by activating telomerase) could enable tumor outgrowth. Thus, such interventions are best reserved for patients with diseases caused by excessively short telomeres.

Read more in Nature Reviews Genetics:

In this Review, the authors discuss recent data showing that telomere attrition is a powerful tumour-suppressor mechanism that limits the development of a wide variety of human cancers.

At the height of the COVID pandemic, people living in high-income countries were already receiving their second vaccine ...
09/01/2026

At the height of the COVID pandemic, people living in high-income countries were already receiving their second vaccine doses, before more than 80 percent of those living in low-income countries had received their first.

For Rockefeller's Barry Coller, this disparity reflected a systemic failure. “This was the dataset that got me,” Coller recalls. “Such disparity, when there was the greatest risk of dying. It hit home.”

Funded in part by the Stavros Niarchos Foundation Institute for Global Infectious Disease Research, Coller set out to explore how researchers could consider issues such as disease burden, licensing, manufacturing, and implementation from the outset, with the goal of making therapies more affordable and accessible in lower income countries. He is now helping to developing a toolkit to designed to help factor equity and affordability into the earliest stages of biomedical discovery.

Researchers show how the senescent state induced by sarcoma and breast cancer drugs drives inflammation—and how it could be suppressed.

08/31/2026

When Rockefeller’s H. Keffer Hartline began his research into visual processing in the 1930s, little was known about the retina, where cells convert external stimuli into neural signals. Throughout his long career, he would go on to make astounding discoveries about the complex interplay between the eye and the brain.

Fascinated by how organisms sense light, Hartline was drawn to the horseshoe crab’s relatively simple visual system, which includes long, easy-to-isolate optic nerve fibers and large photoreceptors in the retina. Among his many innovations was developing groundbreaking methods and tools for isolating single optic nerve fibers in the horseshoe crab eye and then measuring each one’s voltage—the first such recordings in history. These experiments proved his hypothesis that visual information is relayed to the brain through nerve impulses.

Later, he discovered the nerve fiber network that links photoreceptor cells as well as a key form of communication between them: lateral inhibition, or the ability of an excited neuron to mute the activity of its neighbors. This mechanism heightens the contrast between light and shadow and gives sharper edges to shapes—a fine tuning that occurs before an image is even sent to the brain.

For these and other fundamental insights, Hartline won a Nobel Prize in 1967.

As famed biophysicist Floyd Ratliff, a long-time Rockefeller collaborator, said, ''Hartline's basic studies on the integrative action of the retina provided the foundation for practically every advance in the neurophysiology of vision.''

Indeed, Rockefeller’s ninth president and current Vincent and Brooke Astor Professor Emeritus, Torsten Wiesel, built directly upon Hartline’s concepts in his own work discovering how the brain interprets nerve signals to construct images.

For that research into visual processing, Wiesel won a Nobel Prize in 1981.

Don't miss Rockefeller's Paul Cohen on NPR Morning Edition! He discusses his latest work showing that high-intensity tra...
08/27/2026

Don't miss Rockefeller's Paul Cohen on NPR Morning Edition!

He discusses his latest work showing that high-intensity training, like sprinting, provokes a remarkably robust response throughout the bloodstream in a way that moderate exercise does not.

It was clear the sprint group had "many, many more changes," explains Cohen. "What we can conclude is that sprinting does have a greater effect on remodeling the molecules in the bloodstream."

Further analysis showed that the proteins that were altered in the sprinters were associated with improved cardiovascular and metabolic health.

Learn more below.

A new study finds that an all-out sprint may have unique benefits when it comes to the proteins and tiny molecules in your bloodstream.

Rockefeller's Jaejin Kim of the Fuchs lab and Bailey Schultz of the Rock lab have been named Damon Runyon Cancer Researc...
08/25/2026

Rockefeller's Jaejin Kim of the Fuchs lab and Bailey Schultz of the Rock lab have been named Damon Runyon Cancer Research Foundation Fellows! This prestigious fellowship encourages the nation's most promising young scientists to pursue careers in cancer research.

Kim aims to identify the genes and molecular mechanisms underlying tissue memory and to define their consequences for wound repair and tumorigenesis. Identifying the “bad memories” that drive tumorigenesis could open opportunities to selectively erase them—reducing cancer risk without compromising normal regeneration—and may one day help prevent inflammation-linked cancers before they arise.

Schultz is using genome-wide CRISPR-based approaches to identify and study genes that regulate mycobacterial cell growth and division. His work will point to new drug targets and help anticipate possible routes of antibiotic resistance, hopefully leading to new treatments for TB that will ease its burden on cancer patients.

Learn more here: https://bit.ly/4cj7Gby

Rockefeller's Birsoy and Vinogradova labs have teamed up to study how cancer cells rewire their metabolism, and how thes...
08/24/2026

Rockefeller's Birsoy and Vinogradova labs have teamed up to study how cancer cells rewire their metabolism, and how these changes could be targeted therapeutically.

By combining expertise in cancer metabolism, organelle biology, chemical proteomics, and mass spectrometry, the two laboratories are developing new approaches to uncover how metabolic rewiring remodels the functional proteome of cancer cells and how these changes might be therapeutically targeted.

“We are interested in understanding how metabolism regulates protein function during tumor growth and metastasis,” says Birsoy. “If we can identify proteins that respond to specific metabolic changes, we can begin to understand their biological importance and determine whether they represent new therapeutic opportunities.”

🔗: https://bit.ly/4zC8oLk

By deciphering the molecular signatures of millions of mouse cells, Rockefeller's Junyue Cao has found that aging is not...
08/21/2026

By deciphering the molecular signatures of millions of mouse cells, Rockefeller's Junyue Cao has found that aging is not haphazard wear and tear but rather a “remodeling of the cell society.”

“The destruction of the system is programmed at a very early stage,” said Cao.

Using technology that offers a systemwide view of the aging process in mice, Cao has outlined discrete stages of aging, akin to those of embryonic development, that are defined by changes in molecular signals and specific cell populations. In humans, the process likely begins before age 30.

Learn more in this piece from Quanta Magazine:

By deciphering the molecular signatures of millions of mouse cells, Junyue Cao has found that aging is not haphazard wear and tear but rather a “remodeling of the cell society.”

A new study from Viviana Risca's lab at Rockefeller shows how the senescent state induced by   and   drugs drives  .Sene...
08/20/2026

A new study from Viviana Risca's lab at Rockefeller shows how the senescent state induced by and drugs drives .

Senescence is a state in which stressed cells stop dividing but remain alive. The new findings reveal that senescence unfolds in stages—not all at once as previously thought—and that it’s possible to suppress the associated inflammatory response without reversing the cells’ permanent growth arrest.

The results point to a strategy for tuning therapies to avoid inflammation-promoting side effects, particularly for patients with liposarcoma and ER-positive breast cancer.

“We hope this work can help point people toward novel combinations of therapies, or ways to manipulate the senescence response so that we can take the good and leave the bad,” says Risca. “Our work is a combination of basic science and biomedical impact, which may be helpful to extend the lives of patients.”

🔗: https://bit.ly/4wIR5W2

Congratulations to Rockefeller's Krithi Irmady, a 2026 recipient of the Fellows-to-Faculty Award from the Simons Foundat...
08/19/2026

Congratulations to Rockefeller's Krithi Irmady, a 2026 recipient of the Fellows-to-Faculty Award from the Simons Foundation!

Irmady, an assistant professor of clinical investigation and a physician-scientist in the Darnell lab, seeks to understand how RNA regulation shapes synaptic plasticity and neuronal function. She is investigating how RNA-binding proteins control cell-type-specific RNA processing in the brain, and how these mechanisms influence resilience and vulnerability during cognitive and motor aging. By integrating genomics and molecular neuroscience, her work seeks to identify RNA-based mechanisms that can be targeted to preserve brain function with aging.

Learn more here: https://bit.ly/4yXUjrd

Address

1230 York Avenue
New York, NY
10065

Alerts

Be the first to know and let us send you an email when The Rockefeller University posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share